Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Paclitaxel-Coated Devices Don’t Carry Excess Mortality Risk, FDA Says July 12, 2023 Civil Liberties Group Urges FDA to Stop Issuing ‘Improper’ Guidance August 2, 2018 McCaskill Broadens Opioid Investigation to More Manufacturers, Distributors July 27, 2017